Application | Comment | Organism |
---|---|---|
drug development | the enzyme is an important and unique drug target in Acinetobacter baumannii since it plays a key role during the synthesis of peptidoglycan and it is not found in Homo sapiens. In-silico based exploring of potential lead candidates from the library of natural products for the treatment of Acinetobacter baumannii infections is accomplished with the aid of systematic computational analysis. A 3D model of MurG is predicted using comparative protein modeling approach based on homologous MurG structure from Escherichia coli (strain K12) (PDB ID: 1F0K). Concordance binding site analysis is performed to identify the putative ligand binding sites of optimized MurG model for virtual screening and docking studies against natural compounds subset of Zinc database | Acinetobacter baumannii |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
ZINC09186673 | - |
Acinetobacter baumannii | |
ZINC09956120 | - |
Acinetobacter baumannii |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
plasma membrane | - |
Acinetobacter baumannii | 5886 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Acinetobacter baumannii | B0V9F5 | - |
- |
Acinetobacter baumannii AYE | B0V9F5 | - |
- |
Synonyms | Comment | Organism |
---|---|---|
MurG | - |
Acinetobacter baumannii |
General Information | Comment | Organism |
---|---|---|
drug target | the enzyme is an important and unique drug target in Acinetobacter baumannii since it plays a key role during the synthesis of peptidoglycan and it is not found in Homo sapiens | Acinetobacter baumannii |